N-Boc-3-hydroxy-1,2,3,6-tetrahydropyridine
N-Boc-3-hydroxy-1,2,3,6-tetrahydropyridine can increase the activity of β-glucocerebrosidase by 20%. N-Boc-3-hydroxy-1,2,3,6-tetrahydropyridine can be used in the study of lysosomal storage diseases and other protein storage diseases[1].
Product Specifications
CAS Number
[224779-27-5]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Glycosidase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Neurological Disease
Purity
99.70
Smiles
CC(C)(OC(N1CC=CC(C1)O)=O)C
Molecular Formula
C10H17NO3
Molecular Weight
199.25
Precautions
H302, H315, H319, H335
References & Citations
[1]Francis Xavier Wilson, et al. Treatment of lysosomal storage disorders and other proteostatic diseases. WO2010015816A2. Summit Corporation Plc. 2009-08-04.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15198893 1 Vial
Lentiviral mouse Pkn2 shRNA (UAS) - Lentiviral mouse Pkn2 shRNA (UAS) (25)
Sign In for Pricing
View Details 
A4020-01B-AP 100 µL
ATR (FRP1, SCKL1, Ataxia telangiectasia and RAD 3 Related Protein) (AP) discontinued
Sign In for Pricing
View Details 
